Nanocarriers (such as nanoparticles, liposomes, or viral particles) have improved the efficacy and delivery of molecules targeting cGAS-STING, used in the treatment of solid tumors, lymphomas or to potentiate influenza vaccine response (131–133). Here, STING1 is linked to lymphoma.